Related Experiment Video
Updated: Jun 8, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Novel interactions between UFH and TFPI in children
Fiona Newall1, Linda Johnston, Robyn Summerhayes
1Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia. fiona.newall@rch.org.au
British Journal of Haematology
|October 1, 2010
Summary
Children exhibit prolonged tissue factor pathway inhibitor (TFPI) release after unfractionated heparin (UFH) compared to adults, potentially explaining increased bleeding risks and influencing heparin efficacy in pediatric patients.
Area of Science:
- Pediatric Hematology
- Pharmacology
- Coagulation Science
Background:
- Age impacts unfractionated heparin (UFH) response due to changes in coagulation proteins.
- Tissue factor pathway inhibitor (TFPI) release is a key factor in heparin's anticoagulant effect.
Purpose of the Study:
- To compare UFH-induced TFPI release in children versus adults.
- To investigate age-related differences in TFPI pharmacodynamics.
Main Methods:
- Prospective cohort study of children (<16 years) undergoing cardiac angiography.
- Measurement of plasma TFPI levels at baseline and 15, 30, 45, and 120 minutes post-UFH administration.
Main Results:
- Immediate TFPI release post-UFH was similar in children and adults.
- Children showed prolonged and consistent TFPI elevation compared to adults.
- Plasma TFPI levels in children did not decrease with UFH concentration, unlike in adults.
Conclusions:
- Prolonged TFPI release in children may increase major bleeding risk with UFH.
- Sustained TFPI levels could affect UFH binding to plasma proteins, potentially impacting heparin efficacy and heparin-induced thrombocytopenia risk.
